Related by context. All words. (Click for frequent words.) 79 ng dl 77 pg mL 76 ng mL 76 serum testosterone 75 pmol L 74 pg ml 74 nmol L 74 nmol liter 72 mEq L 72 ng ml 72 μg L 72 μmol L 72 mL/min/#.# m 2 71 mm Hg systolic 71 mmol l 70 mg dL 70 mIU L 70 cells uL 70 per deciliter mg 70 g dL 70 mU L 69 mg dl 69 #.#mg/dL 69 mg d 69 alanine aminotransferase 69 hypogonadal 68 aspartate aminotransferase 68 % Confidence Interval 68 bioavailable testosterone 68 g dl 68 mU liter 68 alanine aminotransferase ALT 68 highest tertile 68 #mg/dL [001] 68 hydroxyvitamin D levels 68 ug kg 68 mIU ml 68 serum creatinine levels 68 #.#ng/ml 68 μg dL 68 PSA nadir 67 serum uric acid 67 sUA 67 IU mL 67 specific antigen PSA 67 nmol l 67 mm Hg diastolic 67 microg 67 tPSA 67 μg liter 67 serum urate 67 serum IGF 67 mcg mL 67 serum calcium 67 serum HBV DNA 67 baseline HbA1c 66 mmHg diastolic 66 pmol liter 66 mmHg systolic 66 mg TID 66 mIU mL 66 % CI #.#-#.# [003] 66 umol L 66 aspartate aminotransferase AST 66 -#.# mg dL [002] 66 glycosylated hemoglobin HbA1c 66 μg d 66 REYATAZ r arm 66 preoperative PSA 66 mmol L. 66 dehydroepiandrosterone sulfate 66 HbA 1c 66 CDAI score 66 #ng/ml 66 Fasting blood glucose 65 x ULN 65 CrCl 65 IU ml 65 neutrophil counts 65 hypogonadal men 65 nmol L. 65 oxycodone CR 65 cells μL 65 serum phosphate 65 ml kg 65 mmol L 65 #.#mmol L [002] 65 anemia hemoglobin 65 lispro 65 plasma folate 65 serum cortisol 65 #mmHg [001] 65 serum concentrations 65 serum prostate 65 serum ALT 65 Hb A1C 65 nmol 65 nondiabetic patients 65 baseline Hb 65 CK MB 65 nanograms per 65 aminotransferase levels 65 mcg kg 65 mL/min/#.# m2 65 HBeAg seroconversion 65 ertapenem 65 creatinine clearance 65 eGFR 65 mL min 65 glycated hemoglobin 65 aminotransferases 65 mcg dL 65 #mg/dl 65 lopinavir r arm 65 hip BMD 65 elevated ALT 64 mmol liter 64 serum urate levels 64 X ULN 64 #mg/dL [002] 64 Am J Cardiol 64 hemoglobin A1c HbA1c 64 serum HCV RNA 64 serum PSA 64 degarelix 64 statistical significance p 64 lowest tertile 64 urine albumin 64 Kidney Int 64 Eur Respir J 64 urinary N telopeptide 64 mg/m2/day 64 biochemical recurrence 64 hemoglobin Hb 64 #μg [001] 64 serum estradiol 64 μg mL 64 elevated creatinine 64 mL sec 64 SGPT 64 Crohn Disease Activity 64 μg dl 64 Index CDAI 64 mU 64 ALT elevation 64 hours postdose 64 leukocyte count 64 creatinine ratio 64 lactate dehydrogenase LDH 64 copies ml 64 cGy 64 evaluable subjects 64 aged ≥ 64 Cmax 64 log# copies mL 64 serum phosphorus 64 lumbar spine BMD 64 μmol l 64 troponin T 64 μg ml 64 pCR 64 adjunctive placebo 64 normal ULN 63 uM 63 baseline serum creatinine 63 mg kg Hematide 63 serum sodium 63 biochemical relapse 63 mg m² 63 cells mcL 63 transferrin saturation 63 serum potassium 63 MADRS score 63 thyrotropin 63 mcg linaclotide 63 mg/m2 dose 63 euthyroid 63 μg kg 63 μg l 63 albumin excretion 63 baseline FEV 63 p = .# [002] 63 antibody titer 63 fasting triglyceride levels 63 glycated hemoglobin levels 63 concentration Cmax 63 serum testosterone levels 63 apnea hypopnea index 63 undetectable HBV DNA 63 serum calcium levels 63 CD4 + cell 63 thyroglobulin 63 ml min 63 urinary albumin 63 #mmHg [002] 63 PaO 2 63 serum TSH 63 serum lipid levels 63 HBeAg negative patients 63 HbA 1c levels 63 infliximab monotherapy 63 + PH# 63 #OHD levels 63 plasma uric acid 63 glycated hemoglobin HbA1c 63 nanograms milliliter 63 urinary albumin excretion 63 J Natl Cancer Inst 63 hemoglobin concentrations 63 mcg BID 63 intact parathyroid hormone 63 QTcF 63 mg eq 63 leukopenia 63 lymphocytosis 63 HbA1c levels 63 mg qd 63 â ‰ ¥ 63 iPTH 63 Eur J Endocrinol 63 HGPIN 63 cTnI 62 mmHg 62 #.#/#.# mm Hg [003] 62 isoprostane 62 serum folate 62 LVEF 62 achieved ACR# 62 copies mL 62 PASI scores 62 fasting glucose levels 62 serum homocysteine 62 AUC0 62 undetectable viral 62 serum ferritin 62 thyrotropin levels 62 cTnT 62 Serum creatinine 62 nonfasting triglyceride levels 62 mg kg dose 62 NOAEL 62 PREZISTA ritonavir 62 serum aminotransferase levels 62 urinary cortisol 62 β blocker 62 Index CDAI score 62 #OHD 62 mCi m 2 62 plasma HCV RNA 62 fasting glucose 62 sd = 62 CR nPR 62 mg QD 62 lopinavir r 62 severe neutropenia 62 certolizumab 62 tHcy 62 sUA levels 62 mg orally 62 inhibin B 62 serum magnesium 62 SGOT 62 pT3 62 NPH insulin 62 ìg 62 Hb levels 62 ug mL 62 virologic failure 62 lactate dehydrogenase 62 mEq 62 P = .# 62 fasting blood glucose 62 hydroxyvitamin D 62 baseline A1C 62 OGTT 62 estimated glomerular filtration 62 microgram kg 62 lymphocyte counts 62 #mg/day [001] 62 cells/mm3 62 serum leptin 62 mg Androxal 62 postmenopausal osteoporotic women 62 elevated LDL cholesterol 62 #.#/#.# mmHg [001] 62 Arch Intern Med 62 HOMA IR 62 urinary sodium excretion 61 creatine kinase 61 hypophosphatemia 61 #mg/m# [001] 61 IFN α 61 hyperphenylalaninemia HPA due 61 fasting plasma glucose FPG 61 Non inferiority 61 -#.# log# copies mL 61 #mg BID [003] 61 mg/m2 61 plasma leptin 61 glycosylated hemoglobin 61 SCr 61 pCi l 61 adjunctive ABILIFY 61 mcg QD 61 GnRH agonist 61 nM 61 recurrent VTE 61 A1c levels 61 onset diabetes mellitus 61 % CI #.#-#.# [004] 61 insulin detemir 61 CK # plasma concentrations 61 mcg dose 61 ACR# responses 61 MMSE score 61 moderate renal impairment 61 thyroid stimulating hormone 61 #.#-#.# [011] 61 daily subcutaneous injections 61 saline placebo 61 HBV DNA 61 pg g 61 macroalbuminuria 61 milliliter ng ml 61 antibody titers 61 J Am Soc 61 % CI #.#-#.# [001] 61 #mg #mg #mg [003] 61 mg BID 61 undetectable HCV RNA 61 #mg q8h 61 corticosteroid dose 61 timepoints 61 cortisol concentrations 61 serum vitamin D 61 mg BID dose 61 HBV DNA levels 61 erythrocyte sedimentation rate 61 plasma urate 61 SHBG levels 61 osteopenic 61 Ann Intern Med 61 EDSS score 61 diastolic blood pressures 61 binary restenosis 61 hemoglobin concentration 61 cholesterol LDL C 61 fosamprenavir 61 serum phosphate levels 61 mg q#h 61 systolic BP 61 ejection fractions 61 deciliter 61 % CI #.#-#.# [006] 61 asymptomatic carotid stenosis 61 Hb A1c 61 adiponectin concentrations 61 rFSH 61 PREZISTA r arm 61 calculated creatinine clearance 61 relapsed MM 61 PSADT 61 micrograms mL 61 -#.# ± [002] 61 NovoLog ® Mix 61 Hb 61 ug ml 61 MBq 61 #mg doses [002] 61 mg ustekinumab 61 nonobese 61 log# 61 interquartile range 61 methylmalonic acid 61 creatinine levels 61 NATRECOR R 61 dexamethasone Decadron 61 mm Hg 60 micromoles 60 glomerular filtration rate 60 comparator arm 60 #ug [002] 60 nondiabetic 60 CI #.#-#.# [001] 60 neutrophil count 60 FASEB J. 60 kg/m2 60 HbA1C levels 60 posttreatment 60 HIV RNA 60 μmol 60 LH FSH 60 fasting triglycerides 60 #mg/day [002] 60 alanine transaminase 60 log# reduction 60 mCi 60 mL kg 60 nonfatal MI 60 HIV uninfected 60 N telopeptide 60 NIHSS 60 hsCRP levels 60 plasma cortisol 60 5-FU/LV 60 placebo dexamethasone 60 plasma concentrations 60 nadolol 60 μg 60 hemagglutination inhibition 60 IELT 60 elevated transaminases 60 MIC# [001] 60 NHANES III 60 postintervention 60 definite stent thrombosis 60 median CD4 60 Inhibin B 60 mcg albinterferon alfa 2b 60 transaminases 60 abacavir lamivudine 60 tertile 60 tipranavir r 60 CVD mortality 60 Folfox 60 mcL 60 receiving ISENTRESS 60 hypopneas 60 #.#mmol L [001] 60 J Urol 60 doxorubicin cyclophosphamide 60 -#.# log# 60 mg tid 60 serum glucose 60 ACR# response 60 gastric pH 60 CI -#.# 60 oxycodone IR 60 CIMZIA TM 60 aminotransferase ALT 60 #ppb [001] 60 8mg/kg 60 confidence intervals CIs 60 hepatic enzyme 60 HER2 expression 60 endoscopic remission 60 follicle stimulating hormone FSH 60 hydroxy vitamin D 60 irbesartan 60 Nephrol Dial Transplant 60 serum CRP 60 rapid virological response 60 mean baseline HbA1c 60 Elitek 60 systolic dysfunction 60 thyroid stimulating hormone TSH 60 CC genotype 60 creatine kinase MB 60 incontinence episodes 60 homocysteine concentrations 60 Plasma concentrations 60 Engerix B 60 lymphocyte count 60 μg doses 60 hemoglobin A1c levels 60 nanomoles per 60 mcg doses 60 blood phenylalanine Phe 60 metastatic GIST 60 DAS# remission 60 Psoriasis Area 60 urinary iodine 60 hypokalemia 60 albumin excretion rate 60 interleukin IL -6 60 CDAI 60 serum retinol 60 HbA1C 60 preintervention 60 ± SD 60 mmol 60 Nat Med 59 elevated LDH 59 serum sodium concentration 59 statin monotherapy 59 LEXIVA r 59 placebo p = 59 thromboembolic events 59 normotensive 59 asthma exacerbation 59 ALT elevations 59 Pred Forte 59 reinfarction 59 colorectal adenoma 59 XIENCE V PROMUS Stent 59 detectable HCV RNA 59 CR CRu 59 PREZISTA r 59 triiodothyronine 59 quetiapine XR 59 Baseline characteristics 59 Prehypertension 59 mcg Albuferon 59 mm ³ 59 HDRS 59 HI titers 59 protein excretion 59 4mg/kg 59 titrated glipizide 59 flutamide 59 pmol 59 confidence interval #.#-#.# 59 TEAEs 59 HBeAg positive 59 HbA 1C 59 kcal d 59 oral antidiabetic medication 59 A1C levels 59 glulisine 59 Montgomery Åsberg Depression 59 RLAI 59 chlorambucil 59 lumbar spine bone 59 plasma homocysteine 59 timepoint 59 diastolic BP 59 endometrial thickness 59 mg RDEA# 59 microalbuminuria 59 mg simvastatin 59 atazanavir ritonavir 59 micrograms mcg 59 QT QTc 59 plus prednisone 59 kg m² 59 #mg/m# [002] 59 median PFS 59 rizatriptan 59 fructosamine 59 HCV replicon 59 dapagliflozin plus 59 HIV HCV coinfected 59 DAS# CRP 59 CCyR 59 prospectively defined 59 nicardipine 59 aldosterone antagonist 59 P ≤ 59 serum phosphorus levels 59 serum selenium 59 seroconverted 59 serum albumin 59 TT genotype 59 mg dose 59 Acetate Rectal Suppositories 59 HBeAg 59 mu g 59 mg p = 59 severe exacerbations 59 ACR Pedi 59 Hazard Ratio HR 59 #mg BID [001] 59 Eur Arch 59 advanced adenoma 59 8 OHdG 59 3mg/kg 59 subclinical hypothyroidism 59 kg -1 59 Kaplan Meier estimates 59 BENICAR HCT 59 Nephrol 59 % CI #.#-#.# [007] 59 heterozygotes 59 serum triglycerides 59 LS BMD 59 mm3 59 p = #.# [004] 59 plasma renin 59 mg kg hr 59 abnormal p# biomarker 59 HES CEL 59 elevated serum creatinine 59 nanomolar 59 Lupuzor ™ 59 ‰ ¥ 59 elevated hsCRP 59 #mg/kg [002] 59 elevated troponin 59 lispro alone 59 serum creatinine 59 EBRT 59 advanced adenomas 59 aminotransferase elevations greater 59 fasting plasma 59 prednisone prednisolone 59 Ann Oncol 59 Fasting plasma glucose 59 Fasting glucose 59 oral allopurinol 59 seropositivity 59 HCV RNA 59 LAB GHRH 59 cis retinoic acid 59 urinary calcium 59 intramuscularly 59 creatinine 59 IIIa inhibitors 59 paricalcitol 59 lipid elevations 59 subcutaneous enoxaparin 59 Prostate specific antigen 59 achieved PASI 59 annualized relapse 59 serum phosphorous 59 blood Phe 59 mg calcium 59 unfractionated heparin UFH 59 Nat Genet 59 FIRMAGON 59 p = NS 59 nonfatal stroke 59 ppm Pb 59 receiving INTRON 59 rs# [004] 59 primary hypercholesterolemia 59 μg dose 59 tertiles 59 advanced neoplasia 59 Median survival 59 onset idiopathic hypogonadism 59 mild renal insufficiency 59 J Clin Invest 59 CK # plasma 59 candesartan cilexetil 59 Pharmacokinetic parameters 59 left ventricular systolic 58 MAS XR 58 apolipoprotein B 58 GH deficiency 58 virologic response 58 fraction LVEF 58 tibolone 58 nonfasting triglycerides 58 DAS# [002] 58 FEV1 58 atorvastatin #mg 58 receiving VICTRELIS 58 COZAAR 58 serum bilirubin 58 arterial thromboembolic events 58 follicle stimulating hormone 58 serum transaminases 58 eosinophil count 58 -#.# ± [001] 58 Environ Health Perspect 58 cEVR 58 placebo p 58 ABC/3TC 58 nondiabetics 58 p = #.# [002] 58 hs CRP 58 femoral neck BMD 58 urate lowering therapy 58 isoenzyme 58 Primary endpoints 58 ALT normalization 58 TIMP 1 58 Hemoglobin A1c HbA1c 58 telaprevir dosed 58 NNT = 58 prevalent vertebral fracture 58 fluticasone salmeterol 58 antiandrogen 58 Operative mortality 58 placebo PBO 58 carotid IMT 58 clodronate 58 #ug [001] 58 SBP DBP 58 HBsAg 58 RBC folate 58 confidence interval CI 58 baseline neutrophil counts 58 noncarriers 58 baseline CD4 58 liver histology 58 laboratory abnormalities 58 triglyceride TG 58 ritonavir boosted 58 symptomatic BPH 58 parous women 58 salivary cortisol 58 glomerular filtration 58 arterial oxygen saturation 58 NTx 58 ug L 58 ACR# ACR# 58 ≥ 58 fasting plasma glucose 58 hemodynamically significant 58 REMICADE monotherapy 58 glucuronide 58 plasma glucose concentration 58 micromolar 58 seroprotective 58 IGFBP 58 Peg IFN 58 piotr.skolimowski @ thomson.com 58 nodular partial response 58 n = 58 Peginterferon Alfa 2a 58 insulin glargine 58 elevated uric acid 58 Mg Uk 58 VELCADE melphalan 58 ALT flares 58 Flu Cy 58 #ppb gold 58 urate levels 58 efavirenz EFV 58 plasma glucose levels 58 postoperative mortality 58 loop diuretics 58 d dimer 58 corrected QT interval 58 TAXUS p value 58 nonsignificant difference 58 lipoprotein Lp 58 SUVmax 58 recurrent venous thromboembolism 58 prolactin levels 58 #.#g/day 58 3mg 58 intravaginal ejaculatory latency 58 serum triglyceride levels 58 plus dexamethasone 58 splenectomized patients 58 tolterodine ER 58 LHRH agonists 58 serum PTH 58 glargine 58 transaminase levels 58 low dose cytarabine 58 cardiac troponin T 58 severe renal impairment 58 6mg 58 plasma triglycerides 58 p ≤ 58 BLLs 58 underwent surgical resection 58 serum LDL cholesterol 58 FOLPI 58 Syndr 58 log# IU mL 58 receiving Vectibix monotherapy 58 medroxyprogesterone acetate 58 ug dose 58 IDDM 58 mg/# [002] 58 mcg kg min 58 CRp 58 APTIVUS r 58 kBq kg 58 AST ALT 58 r2 = 58 budesonide pMDI 58 subtrochanteric 58 MACCE 58 Left Ventricular Ejection Fraction 58 ug dL 58 BMI ≥ 58 CHD mortality 58 % CI #.#-#.# [008] 58 SCIg 58 detemir 58 salmeterol fluticasone propionate 58 triglycerides TG 58 mineral density 58 deep venous thromboses 58 mg 58 generalized edema 58 octreotide LAR 58 CIN2 58 rapid virologic response 58 #q# deletion syndrome 58 estradiol 58 min -1 58 QRS duration 58 diabetes mellitus DM 58 Expanded Disability Status 58 density lipoprotein cholesterol 57 lymphopenia 57 morphometric vertebral fractures 57 univariate analysis 57 DAS# scores 57 mg subcutaneously 57 SSRI SNRI 57 antigen PSA 57 transaminase elevations 57 coronary stenosis 57 suppl. 57 salmeterol fluticasone 57 CIN2 + 57 serum potassium levels 57 oral glucose tolerance 57 J Physiol 57 ARCOXIA 57 ritonavir boosted atazanavir 57 simvastatin #mg 57 periprocedural 57 β blockers 57 anti HBs 57 estimated GFR 57 HBeAg negative 57 receiving prophylactic anticoagulation 57 hyperphosphatemia elevated serum phosphorous 57 seropositive patients 57 microalbumin 57 Ishak fibrosis score 57 hematologic toxicity 57 Mg Usa 57 serum parathyroid hormone 57 ULORIC 57 platelet reactivity 57 prehypertensive 57 partial remissions 57 steroid dexamethasone 57 urinary excretion 57 azilsartan medoxomil 57 mcg dl 57 intima media thickness 57 % CI #.#-#.# [005] 57 systemic corticosteroid 57 ACTH 57 hsCRP 57 nonpregnant women 57 ropivacaine 57 transdermal estradiol 57 EDSS scores 57 Secondary efficacy endpoints 57 parathyroid hormone PTH 57 HAM D# scores 57 mcg kg REBETOL 57 peginterferon alfa 2a 57 piperacillin tazobactam 57 J Biol Chem 57 MCyR 57 adverse reactions incidence 57 paraprotein 57 goserelin 57 p = #.# [003] 57 seronegative 57 platelet counts 57 posaconazole 57 μSv 57 sFlt 1 57 hematological parameters 57 milliliter ng mL 57 ONGLYZA saxagliptin 57 HbA1c 57 discontinuations due 57 splenectomized 57 #.#mg [003] 57 histological subtype 57 femtogram 57 undetectable viral load 57 epoetin alpha 57 abstr 57 HMG CoA reductase inhibitory 57 myocardial infarction stroke 57 follicular phase 57 amprenavir 57 Response Evaluation Criteria 57 specific alkaline phosphatase 57 plasma glucose 57 cervical intraepithelial neoplasia 57 leukocytosis 57 ug dl 57 desvenlafaxine succinate 57 transaminase elevations greater 57 D dimer 57 fractional shortening 57 complete cytogenetic 57 dose colchicine 57 FluCAM arm 57 nitroprusside 57 oral prednisone 57 UACR 57 CsA 57 FTE staffing 57 epoetin alfa 57 #mg/kg [001] 57 #/#mmHg 57 systemic embolism 57 CIN3 57 prolonged QT interval 57 REYATAZ r 57 milligrams mg 57 OADs 57 KRAS mutations occur 57 gm dl 57 bFGF 57 abdominal adiposity 57 adenoma recurrence 57 MMSE scores 57 doxorubicin docetaxel 57 mRS 57 affective psychosis 57 GH secretion 57 Cardiovasc Res 57 Myelosuppression 57 ASCUS 57 #.#mmol l [002] 57 fluvastatin 57 active comparator 57 mg dosed twice 57 alfuzosin 57 μg g 57 reticulocytes 57 prednisone prednisolone plus 57 AEGR 57 -8 -9 57 KRAS mutations 57 HIV seronegative 57 treatment naļve 57 serum sodium levels 57 mRNA expression 57 nonfatal myocardial infarction 57 Eur J Pharmacol 57 diastolic hypertension 57 crossclamp 57 homozygotes 57 darbepoetin alfa 57 COPD exacerbation 57 fasting insulin 57 PEG Interferon alfa 57 highly emetogenic 57 Bq/m3 57 Scale EDSS score 57 PCWP 57 Abstract Free Full Text 57 IPSS 57 zoledronate 57 malondialdehyde MDA 57 mol L 57 ovarian carcinoma 57 CYP#A# [002] 57 tHcy concentrations 57 bone marrow reticulin 57 neurodevelopmental impairment 57 CRESTOR #mg 57 EURIDIS 57 beta blocker therapy 57 PCA3 scores 57 #.#mg/kg [002] 57 plasma concentration Cmax 57 BMS p = 57 LV ejection fraction 57 #/#mg 57 adefovir treated 57 tamsulosin 57 dose cohort 57 PON1 enzyme 57 hydroxymethyl coenzyme 57 triglycerides ≥ 57 maternal serum 57 coinfected 57 reduce serum phosphate 57 LDL triglycerides 57 arterial thickening 57 Suppl. 57 histologic subtype 57 bortezomib refractory 57 mmol kg 57 carotid stenosis 57 serum antibody 57 multivariable adjusted 57 dosing cohort 57 μM 57 IBDQ 57 somatostatin analog 57 plus prednisone prednisolone 57 cytarabine daunorubicin 57 mediated dilation 57 tryptase 57 grade cervical intraepithelial 57 ketorolac 56 Kaplan Meier analysis 56 nonvertebral fractures 56 hMG 56 milliliters mL 56 NIHSS score 56 estramustine 56 CHD CVD 56 erection hardness 56 hyperoxia 56 alemtuzumab treated 56 androgen deprivation 56 hydroxyvitamin D concentrations